• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结合不同分析策略对低分子量肝素达肝素进行结构表征

Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies.

作者信息

Bisio Antonella, Urso Elena, Guerrini Marco, de Wit Pauline, Torri Giangiacomo, Naggi Annamaria

机构信息

Istituto di Ricerche Chimiche e Biochimiche G. Ronzoni, 20133 Milan, Italy.

Department of Cell and Applied Biology, Faculty of Science, Radboud University Nijmegen, 6525 HP Nijmegen, The Netherlands.

出版信息

Molecules. 2017 Jun 24;22(7):1051. doi: 10.3390/molecules22071051.

DOI:10.3390/molecules22071051
PMID:28672818
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6152074/
Abstract

A number of low molecular weight heparin (LMWH) products are available for clinical use and although all share a similar mechanism of action, they are classified as distinct drugs because of the different depolymerisation processes of the native heparin resulting in substantial pharmacokinetic and pharmacodynamics differences. While enoxaparin has been extensively investigated, little information is available regarding the LMWH dalteparin. The present study is focused on the detailed structural characterization of Fragmin by LC-MS and NMR applied both to the whole drug and to its enzymatic products. For a more in-depth approach, size homogeneous octasaccharide and decasaccharide components together with their fractions endowed with high or no affinity toward antithrombin were also isolated and their structural profiles characterized. The combination of different analytical strategies here described represents a useful tool for the assessment of batch-to-batch structural variability and for comparative evaluation of structural features of biosimilar products.

摘要

有多种低分子量肝素(LMWH)产品可供临床使用,尽管它们都具有相似的作用机制,但由于天然肝素的解聚过程不同,导致其药代动力学和药效学存在显著差异,因此被归类为不同的药物。虽然依诺肝素已得到广泛研究,但关于低分子量肝素达肝素的信息却很少。本研究聚焦于通过液相色谱-质谱联用(LC-MS)和核磁共振(NMR)对法安明进行详细的结构表征,该方法同时应用于整个药物及其酶解产物。为了进行更深入的研究,还分离了大小均一的八糖和十糖组分及其对抗凝血酶具有高亲和力或无亲和力的馏分,并对其结构特征进行了表征。这里描述的不同分析策略的组合是评估批次间结构变异性以及对生物类似产品结构特征进行比较评估的有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/1f8f29b03293/molecules-22-01051-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/f8eca5b8d795/molecules-22-01051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/e99bdab66c34/molecules-22-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/a9968352ee5a/molecules-22-01051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/e71f4a12fd49/molecules-22-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/c281f5f16811/molecules-22-01051-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/aa058df961ea/molecules-22-01051-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/1f8f29b03293/molecules-22-01051-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/f8eca5b8d795/molecules-22-01051-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/e99bdab66c34/molecules-22-01051-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/a9968352ee5a/molecules-22-01051-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/e71f4a12fd49/molecules-22-01051-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/c281f5f16811/molecules-22-01051-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/aa058df961ea/molecules-22-01051-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8f09/6152074/1f8f29b03293/molecules-22-01051-g007.jpg

相似文献

1
Structural Characterization of the Low-Molecular-Weight Heparin Dalteparin by Combining Different Analytical Strategies.结合不同分析策略对低分子量肝素达肝素进行结构表征
Molecules. 2017 Jun 24;22(7):1051. doi: 10.3390/molecules22071051.
2
Characterization of Low-Molecular-Weight Heparins by Strong Anion-Exchange Chromatography.通过强阴离子交换色谱法对低分子量肝素进行表征
J AOAC Int. 2017 Nov 1;100(6):1706-1714. doi: 10.5740/jaoacint.17-0217. Epub 2017 Jul 13.
3
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.糖解低分子量肝素的结构特征及其肝素裂解酶产生的片段。
Anal Bioanal Chem. 2014 Jan;406(1):249-65. doi: 10.1007/s00216-013-7446-4. Epub 2013 Nov 20.
4
Structural features of low-molecular-weight heparins affecting their affinity to antithrombin.影响低分子量肝素与抗凝血酶亲和力的结构特征。
Thromb Haemost. 2009 Nov;102(5):865-73. doi: 10.1160/TH09-02-0081.
5
Sequencing the oligosaccharide pool in the low molecular weight heparin dalteparin with offline HPLC and ESI-MS/MS.采用离线 HPLC 和 ESI-MS/MS 对低分子量肝素达肝素中的寡糖池进行测序。
Carbohydr Polym. 2018 Mar 1;183:81-90. doi: 10.1016/j.carbpol.2017.11.039. Epub 2017 Nov 13.
6
Complete Molecular Weight Profiling of Low-Molecular Weight Heparins Using Size Exclusion Chromatography-Ion Suppressor-High-Resolution Mass Spectrometry.采用体积排阻色谱-离子抑制-高分辨质谱法对低分子量肝素进行完整的分子量谱分析。
Anal Chem. 2016 Nov 1;88(21):10654-10660. doi: 10.1021/acs.analchem.6b03081. Epub 2016 Oct 17.
7
Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.亲水作用色谱-多反应监测质谱法用于亚硝酸解聚制备的低分子量肝素基本组成单元分析
J Chromatogr A. 2017 Jan 6;1479:121-128. doi: 10.1016/j.chroma.2016.11.061. Epub 2016 Nov 30.
8
Pharmacokinetics of UH and LMWH are similar with respect to antithrombin activity.就抗凝血酶活性而言,普通肝素(UH)和低分子量肝素(LMWH)的药代动力学相似。
Thromb Res. 2005;115(1-2):45-51. doi: 10.1016/j.thromres.2004.07.010.
9
In vitro heparinization of canine whole blood with low molecular weight heparin (dalteparin) significantly and dose-dependently prolongs heparinase-modified tissue factor-activated thromboelastography parameters and prothrombinase-induced clotting time.用低分子量肝素(达肝素)对犬全血进行体外肝素化,可显著且呈剂量依赖性地延长肝素酶修饰的组织因子激活的血栓弹力图参数及凝血酶原酶诱导的凝血时间。
Vet Clin Pathol. 2008 Dec;37(4):363-72. doi: 10.1111/j.1939-165X.2008.00068.x.
10
Liquid chromatography-diode array detection-mass spectrometry for compositional analysis of low molecular weight heparins.液相色谱-二极管阵列检测-质谱联用技术用于低分子量肝素的成分分析
Anal Biochem. 2014 Apr 15;451:35-41. doi: 10.1016/j.ab.2014.02.005. Epub 2014 Feb 14.

引用本文的文献

1
Commercial Low Molecular Weight Heparins - Patent Ecosystem and Technology Paradigm for Quality Characterization.商业低分子量肝素——质量表征的专利生态系统与技术范式
J Pharm Innov. 2022 Jul 28:1-33. doi: 10.1007/s12247-022-09665-7.
2
The interaction between oxytocin and heparin.催产素与肝素之间的相互作用。
RSC Adv. 2020 Jul 29;10(47):28300-28313. doi: 10.1039/d0ra04204h. eCollection 2020 Jul 27.
3
Heparanase as an Additional Tool for Detecting Structural Peculiarities of Heparin Oligosaccharides.肝素酶作为检测肝素寡糖结构特征的附加工具。

本文引用的文献

1
Synthesis of 3-O-Sulfated Oligosaccharides to Understand the Relationship between Structures and Functions of Heparan Sulfate.3-O-硫酸化寡糖的合成以了解硫酸乙酰肝素结构与功能之间的关系。
J Am Chem Soc. 2017 Apr 12;139(14):5249-5256. doi: 10.1021/jacs.7b01923. Epub 2017 Apr 3.
2
Qualification of HSQC methods for quantitative composition of heparin and low molecular weight heparins.用于肝素和低分子肝素定量组成分析的HSQC方法的验证
J Pharm Biomed Anal. 2017 Mar 20;136:92-105. doi: 10.1016/j.jpba.2016.12.031. Epub 2016 Dec 26.
3
Hydrophilic interaction chromatography-multiple reaction monitoring mass spectrometry method for basic building block analysis of low molecular weight heparins prepared through nitrous acid depolymerization.
Molecules. 2019 Dec 2;24(23):4403. doi: 10.3390/molecules24234403.
4
Biosimilars of low molecular weight heparins: Relevant background information for your drug formulary.低分子肝素生物类似药:您的药品处方集的相关背景信息。
Br J Clin Pharmacol. 2019 Nov;85(11):2479-2486. doi: 10.1111/bcp.14081. Epub 2019 Sep 4.
5
Looking Forward to the Future of Heparin: New Sources, Developments and Applications.展望肝素的未来:新来源、新进展和新应用。
Molecules. 2018 Jan 31;23(2):293. doi: 10.3390/molecules23020293.
亲水作用色谱-多反应监测质谱法用于亚硝酸解聚制备的低分子量肝素基本组成单元分析
J Chromatogr A. 2017 Jan 6;1479:121-128. doi: 10.1016/j.chroma.2016.11.061. Epub 2016 Nov 30.
4
Development of hydrophilic interaction chromatography with quadruple time-of-flight mass spectrometry for heparin and low molecular weight heparin disaccharide analysis.用于肝素和低分子肝素二糖分析的亲水相互作用色谱与四极杆飞行时间质谱联用技术的开发。
Rapid Commun Mass Spectrom. 2016 Jan 30;30(2):277-84. doi: 10.1002/rcm.7437.
5
Determination of the molecular weight of low-molecular-weight heparins by using high-pressure size exclusion chromatography on line with a triple detector array and conventional methods.采用带三重检测器阵列的高压尺寸排阻色谱法在线测定低分子量肝素的分子量及常规方法。
Molecules. 2015 Mar 19;20(3):5085-98. doi: 10.3390/molecules20035085.
6
Structural features of glycol-split low-molecular-weight heparins and their heparin lyase generated fragments.糖解低分子量肝素的结构特征及其肝素裂解酶产生的片段。
Anal Bioanal Chem. 2014 Jan;406(1):249-65. doi: 10.1007/s00216-013-7446-4. Epub 2013 Nov 20.
7
Novel reverse-phase ion pair-high performance liquid chromatography separation of heparin, heparan sulfate and low molecular weight-heparins disaccharides and oligosaccharides.新型反相离子对高效液相色谱法分离肝素、硫酸乙酰肝素和低分子量肝素二糖和寡糖。
J Chromatogr A. 2013 Apr 5;1284:141-7. doi: 10.1016/j.chroma.2013.02.013. Epub 2013 Feb 11.
8
Reversed-phase ion-pair ultra-high-performance-liquid chromatography-mass spectrometry for fingerprinting low-molecular-weight heparins.反相离子对超高效液相色谱-质谱联用技术用于指纹分析低分子量肝素。
J Chromatogr A. 2013 May 31;1292:201-10. doi: 10.1016/j.chroma.2013.01.011. Epub 2013 Jan 10.
9
Structural analysis of low molecular weight heparin by ultraperformance size exclusion chromatography/time of flight mass spectrometry and capillary zone electrophoresis.采用超高效尺寸排阻色谱/飞行时间质谱法和毛细管区带电泳法对低分子量肝素进行结构分析。
Anal Chem. 2013 Feb 5;85(3):1819-27. doi: 10.1021/ac303185w. Epub 2013 Jan 17.
10
Profiling glycol-split heparins by high-performance liquid chromatography/mass spectrometry analysis of their heparinase-generated oligosaccharides.通过高效液相色谱/质谱分析肝素酶产生的寡糖对糖基化肝素进行分析。
Anal Biochem. 2013 Mar 1;434(1):112-22. doi: 10.1016/j.ab.2012.11.011. Epub 2012 Nov 29.